GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telomir Pharmaceuticals Inc (NAS:TELO) » Definitions » Accounts Payable

Telomir Pharmaceuticals (Telomir Pharmaceuticals) Accounts Payable : $0.48 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Telomir Pharmaceuticals Accounts Payable?

Telomir Pharmaceuticals's Accounts Payable for the quarter that ended in Mar. 2024 was $0.48 Mil.

Telomir Pharmaceuticals's quarterly Accounts Payable increased from Sep. 2023 ($0.50 Mil) to Dec. 2023 ($0.71 Mil) but then declined from Dec. 2023 ($0.71 Mil) to Mar. 2024 ($0.48 Mil).

Telomir Pharmaceuticals's annual Accounts Payable increased from Dec. 2021 ($0.02 Mil) to Dec. 2022 ($0.40 Mil) and increased from Dec. 2022 ($0.40 Mil) to Dec. 2023 ($0.71 Mil).

Telomir Pharmaceuticals Accounts Payable Historical Data

The historical data trend for Telomir Pharmaceuticals's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telomir Pharmaceuticals Accounts Payable Chart

Telomir Pharmaceuticals Annual Data
Trend Dec21 Dec22 Dec23
Accounts Payable
0.02 0.40 0.71

Telomir Pharmaceuticals Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Payable Get a 7-Day Free Trial Premium Member Only - 0.85 0.50 0.71 0.48

Telomir Pharmaceuticals Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Telomir Pharmaceuticals Accounts Payable Related Terms

Thank you for viewing the detailed overview of Telomir Pharmaceuticals's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Telomir Pharmaceuticals (Telomir Pharmaceuticals) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telomir Pharmaceuticals Inc (NAS:TELO) » Definitions » Accounts Payable
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.

Telomir Pharmaceuticals (Telomir Pharmaceuticals) Headlines

From GuruFocus

UPDATE -- Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines

By GlobeNewswire • 03-29-2024